Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124625274 | 12462527 | 4 | F | 20160602 | 20160704 | 20160614 | 20160706 | EXP | GB-ROCHE-1773068 | ROCHE | 57.89 | YR | F | Y | 0.00000 | 20160706 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124625274 | 12462527 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 103792 | 600 | MG | SOLUTION FOR INJECTION | |||||||
| 124625274 | 12462527 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | LAST ADMINISTERED 01/JUN/2016 | U | 0 | 6 | MG | |||||||
| 124625274 | 12462527 | 3 | C | APREPITANT. | APREPITANT | 1 | 0 | ||||||||||||
| 124625274 | 12462527 | 4 | C | DOCETAXEL. | DOCETAXEL | 1 | 0 | ||||||||||||
| 124625274 | 12462527 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 124625274 | 12462527 | 6 | C | BENZYDAMINE | BENZYDAMINE | 1 | 0 | ||||||||||||
| 124625274 | 12462527 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124625274 | 12462527 | 1 | Product used for unknown indication |
| 124625274 | 12462527 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124625274 | 12462527 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124625274 | 12462527 | Alopecia | |
| 124625274 | 12462527 | Arthralgia | |
| 124625274 | 12462527 | Asthenia | |
| 124625274 | 12462527 | Chromaturia | |
| 124625274 | 12462527 | Dysgeusia | |
| 124625274 | 12462527 | Fatigue | |
| 124625274 | 12462527 | Myalgia | |
| 124625274 | 12462527 | Nausea | |
| 124625274 | 12462527 | Oral pain | |
| 124625274 | 12462527 | Vein discolouration | |
| 124625274 | 12462527 | Vein disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124625274 | 12462527 | 1 | 20160531 | 0 |